Nirdosh Kumar Gogna

720 total citations
13 papers, 430 citations indexed

About

Nirdosh Kumar Gogna is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Nirdosh Kumar Gogna has authored 13 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiation and 3 papers in Surgery. Recurrent topics in Nirdosh Kumar Gogna's work include Prostate Cancer Diagnosis and Treatment (9 papers), Prostate Cancer Treatment and Research (8 papers) and Advanced Radiotherapy Techniques (6 papers). Nirdosh Kumar Gogna is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (9 papers), Prostate Cancer Treatment and Research (8 papers) and Advanced Radiotherapy Techniques (6 papers). Nirdosh Kumar Gogna collaborates with scholars based in Australia, New Zealand and Japan. Nirdosh Kumar Gogna's co-authors include Sandra Turner, Gillian Duchesne, Nigel Spry, David Joseph, John Matthews, James W. Denham, Chris Atkinson, Liz Kenny, David S. Lamb and Brett Delahunt and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Nirdosh Kumar Gogna

13 papers receiving 425 citations

Peers

Countries citing papers authored by Nirdosh Kumar Gogna

Since Specialization

Citations

This map shows the geographic impact of Nirdosh Kumar Gogna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirdosh Kumar Gogna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirdosh Kumar Gogna more than expected).

Fields of papers citing papers by Nirdosh Kumar Gogna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirdosh Kumar Gogna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirdosh Kumar Gogna. The network helps show where Nirdosh Kumar Gogna may publish in the future.

Co-authorship network of co-authors of Nirdosh Kumar Gogna

This figure shows the co-authorship network connecting the top 25 collaborators of Nirdosh Kumar Gogna. A scholar is included among the top collaborators of Nirdosh Kumar Gogna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirdosh Kumar Gogna. Nirdosh Kumar Gogna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Implementation of 3D conformal radiotherapy technology at the National Cancer Centre Mongolia: A successful Asia‐Pacific collaborative initiative 2021 ·Journal of Medical Imaging and Radiation Oncology ·Eng‐Siew Koh, Nirdosh Kumar Gogna, (unknown), (unknown), (unknown), (unknown), (unknown), Mei Ling Yap, (unknown), Cesar E. Ochoa, (unknown), Toby Lowe, (unknown), (unknown), (unknown), Iain Ward	5
2	Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial 2018 ·The Lancet Oncology ·James W. Denham, David Joseph, David S. Lamb, Nigel Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen‐Hun Tai, David Christie, Liz Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terry Diamond, Brett Delahunt, Christopher Oldmeadow, John Attia, Allison Steigler	69
3	Main oncologic endpoints of the TROG 03.04 (RADAR) Trial for men with locally advanced prostate cancer 2014 ·Journal of Clinical Oncology ·James W. Denham, David Joseph, David S. Lamb, Nigel Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen Hun Tai, David Christie, Liz Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terrence Diamond, Brett Delahunt, John Attia, Allison Steigler	1
4	Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial 2014 ·The Lancet Oncology ·James W. Denham, David Joseph, David S. Lamb, Nigel Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen‐Hun Tai, David Christie, Liz Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terry Diamond, Brett Delahunt, Christopher Oldmeadow, John Attia, Allison Steigler	117
5	Split-Course, High-Dose Palliative Pelvic Radiotherapy for Locally Progressive Hormone-Refractory Prostate Cancer 2012 ·International Journal of Radiation OncologyBiologyPhysics ·Nirdosh Kumar Gogna, Siddhartha Baxi, Brigid E Hickey, Kathryn Baumann, Elizabeth Burmeister, Tanya Holt	16
6	Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial 2012 ·The Lancet Oncology ·James W. Denham, (unknown), David Joseph, Nigel Spry, David S. Lamb, (unknown), John Matthews, Chris Atkinson, Sandra Turner, David Christie, Nirdosh Kumar Gogna, Liz Kenny, Gillian Duchesne, Brett Delahunt, Patrick McElduff	46
7	Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer 2012 ·Radiotherapy and Oncology ·James W. Denham, (unknown), David S. Lamb, Nigel Spry, Gillian Duchesne, Chris Atkinson, John Matthews, Sandra Turner, Liz Kenny, (unknown), Nirdosh Kumar Gogna, Martin A. Ebert, Brett Delahunt, Patrick McElduff, David Joseph	35
8	Australian & New Zealand Faculty of Radiation Oncology Genito‐Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder 2012 ·Journal of Medical Imaging and Radiation Oncology ·(unknown), Sandra Turner, Jeremy Millar, Farshad Foroudi, Nirdosh Kumar Gogna, Marketa Skala, Andrew Kneebone, David Christie, Margot Lehman, Kirsty Wiltshire, Keen‐Hun Tai	12
9	‘GAP’ in radiotherapy services in Australia and New Zealand in 2009 2010 ·Journal of Medical Imaging and Radiation Oncology ·(unknown), Michael Bartoň, Callum Atkinson, Jeremy Millar, Nirdosh Kumar Gogna, Eric Yeoh	11
10	An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Scott Williams, Gillian Duchesne, Nirdosh Kumar Gogna, Jeremy Millar, Tom Pickles, Gary Pratt, Sandra Turner	22
11	Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group 2006 ·Radiotherapy and Oncology ·Nirdosh Kumar Gogna, J. H. Matthews, Sandra Turner, (unknown), Gillian Duchesne, Nigel Spry, Martin Berry, Jacqui Keller, Lee Tripcony	56
12	Outcome, morbidity, and prognostic factors in post-prostatectomy radiotherapy: an Australian multicenter study 2003 ·Urology ·Gillian Duchesne, Caroline Dowling, Mark Frydenberg, David Joseph, Nirdosh Kumar Gogna, (unknown), (unknown), Nigel Spry, Sandra Turner, Henry H. Woo	18
13	Lung dose rate and interstitial pneumonitis in total body irradiation for bone marrow transplantation 1992 ·Australasian Radiology ·Nirdosh Kumar Gogna, Graeme Morgan, (unknown), K Atkinson, J. C. Biggs	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact